Clinical Trials during the SARS-CoV-2 Pandemic
- PMID: 32289798
- PMCID: PMC7179533
- DOI: 10.1159/000507582
Clinical Trials during the SARS-CoV-2 Pandemic
Conflict of interest statement
Dr. Warnock has not relevant conflict of interests.
Comment on
-
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.Nephron. 2020;144(5):213-221. doi: 10.1159/000507305. Epub 2020 Mar 23. Nephron. 2020. PMID: 32203970 Free PMC article. Review.
References
-
- Boulware D. Post-exposure prophylaxis for sars-coronavirus-2 (nct04308668): ClinicalTrialsgov 2020, 2020, 4 Batlle D, Wysocki J, Satchell K: soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci. 2020;134:543–5. - PubMed
-
- Batlle D, Wysocki J, Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clinical Science. 2020;134((5)):543–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
